You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 10, 2025

Details for Patent: 10,961,190


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,961,190 protect, and when does it expire?

Patent 10,961,190 protects XERAVA and is included in one NDA.

This patent has twelve patent family members in nine countries.

Summary for Patent: 10,961,190
Title:Crystalline forms of eravacycline
Abstract: The invention relates to crystalline forms of the bis-HCI salt of a compound represented by Structural Formula 1, and pharmaceutical compositions comprising crystalline forms of the bis-HCL salt of a compound represented by Structural Formula 1 described herein. The crystalline forms of the bis-HCl salt of a compound of Structural Formula 1 and compositions comprising the crystalline forms of the compound of Structural Formula 1 provided herein, in particular, crystalline Form I, crystalline Form J, crystalline Form A, and crystalline Form B, or mixtures thereof, can be incorporated into pharmaceutical compositions, which can be used to treat various disorders. Also described herein are methods for preparing the crystalline forms (e.g., Forms I, J, B and A) of the bis-HCI salt of a compound represented by Structural Formula 1. ##STR00001##
Inventor(s): LaFrance; Danny (Natick, MA), Hogan; Philip C. (Brighton, MA), Liu; Yansheng (Winchester, MA), He; Minsheng (Andover, MA), Chen; Chi-Li (Newton, MA), Niu; John (Bedford, MA)
Assignee: Tetraphase Pharmaceuticals, Inc. (Watertown, MA)
Application Number:16/342,779
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using US Patent 10,961,190 as an Example

Introduction to Patent Analysis

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. Here, we will use U.S. Patent 10,961,190 as an example to delve into the key aspects of patent analysis.

Understanding Patent Scope

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is a critical factor in determining the patent's value and its potential to inhibit or encourage innovation[3].

Metrics for Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can provide insights into the breadth and clarity of the patent claims. For instance, narrower claims with fewer words and fewer independent claims are generally associated with a higher probability of grant and a shorter examination process[3].

Patent Claims Analysis

Types of Claims

Patent claims can be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim.

Claim Language and Structure

The language and structure of claims are vital. Clear and concise claims are more likely to be granted and enforced. The USPTO examines claims for clarity, novelty, and non-obviousness. For example, in U.S. Patent 10,961,190, the independent claims should be scrutinized for their specificity and breadth to understand the exact scope of the invention.

Step-by-Step Analysis of U.S. Patent 10,961,190

Identifying the Invention

To begin, identify the invention described in the patent. This involves reading the abstract, summary, and detailed description sections to understand the core concept and its applications.

Reviewing the Claims

  • Independent Claims: Analyze the independent claims to determine the broadest scope of protection. These claims should be clear, concise, and well-defined.
  • Dependent Claims: Examine the dependent claims to see how they further limit the independent claims, adding specificity and narrowing the scope.

Evaluating Claim Language

  • Clarity: Ensure the language used in the claims is clear and unambiguous.
  • Breadth: Determine the breadth of the claims by analyzing the independent claim length and count. Narrower claims are generally more enforceable[3].

Assessing Prior Art and Novelty

Use tools like the USPTO's Patent Public Search or international databases such as the European Patent Office's esp@cenet or WIPO's PATENTSCOPE to search for prior art. This helps in understanding whether the invention is novel and non-obvious over existing technologies[1].

Patent Landscape Analysis

Global Dossier and International Search

Utilize the Global Dossier service to view the patent family for the specific application, including related applications filed at participating IP Offices. This helps in understanding the global patent landscape and potential overlaps or conflicts[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP Offices, providing a single point of access to prior art cited by multiple offices. This is useful for visualizing the search results for the same invention across different jurisdictions[1].

Tools and Resources for Patent Analysis

USPTO Resources

  • Patent Public Search: A powerful tool for searching prior art and understanding the patent landscape.
  • Patent and Trademark Resource Centers (PTRCs): Local centers that offer training and resources for patent searching.
  • Public Search Facility: Located in Alexandria, VA, this facility provides access to patent and trademark information in various formats[1].

International Databases

  • European Patent Office (EPO): Provides access to European patent databases through esp@cenet.
  • Japan Patent Office (JPO): Offers machine translations of Japanese patents.
  • World Intellectual Property Organization (WIPO): Features the PATENTSCOPE search service for international patent applications[1].

Legal and Regulatory Considerations

Patent Subject Matter Eligibility

Ensure the patent complies with the revised subject matter eligibility guidance, which includes a detailed analysis under the Alice/Mayo test. This is crucial for determining whether the invention falls within eligible subject matter[4].

Office Actions and Examination Data

Use the Patent Examination Data System (PEDS) to access and analyze the examination history of the patent, including office actions and any changes made during the examination process. This can provide insights into the patent's validity and potential challenges[1].

Practical Applications and Market Impact

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation strategies. Broader claims may lead to more licensing opportunities but also increase the risk of litigation. Narrower claims, while more enforceable, may limit licensing potential[3].

Innovation Incentives

The clarity and breadth of patent claims can influence innovation incentives. Clear and well-defined claims can encourage innovation by providing a clear understanding of what is protected and what is not[3].

Key Takeaways

  • Clear Claims: Ensure claims are clear, concise, and well-defined to enhance enforceability.
  • Breadth of Claims: Analyze the breadth of claims using metrics like independent claim length and count.
  • Prior Art: Conduct thorough prior art searches to ensure novelty and non-obviousness.
  • Global Landscape: Use tools like Global Dossier and CCD to understand the global patent landscape.
  • Legal Compliance: Ensure compliance with subject matter eligibility guidelines and other regulatory requirements.

FAQs

Q: How do I conduct a preliminary U.S. patent search?

A: You can use the USPTO's Patent Public Search tool, visit a Patent and Trademark Resource Center, or access international databases like esp@cenet or PATENTSCOPE[1].

Q: What are the key metrics for measuring patent scope?

A: Independent claim length and independent claim count are commonly used metrics to measure patent scope[3].

Q: Why is the clarity of patent claims important?

A: Clear claims are more likely to be granted and enforced, reducing the risk of litigation and increasing the patent's value.

Q: How can I access the examination history of a patent?

A: Use the Patent Examination Data System (PEDS) to access and analyze the examination history, including office actions and changes made during the examination process[1].

Q: What is the Global Dossier service, and how is it useful?

A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users understand the global patent landscape and identify potential overlaps or conflicts[1].

Sources

  1. USPTO: "Search for patents - USPTO" - https://www.uspto.gov/patents/search
  2. USA.gov: "U.S. Patent and Trademark Office (USPTO) | USAGov" - https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN: "Patent Claims and Patent Scope" - https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Federal Register: "2019 Revised Patent Subject Matter Eligibility Guidance" - https://unblock.federalregister.gov/

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,961,190

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Tetraphase Pharms XERAVA eravacycline dihydrochloride POWDER;INTRAVENOUS 211109-001 Aug 27, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Tetraphase Pharms XERAVA eravacycline dihydrochloride POWDER;INTRAVENOUS 211109-002 Jun 3, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,961,190

PCT Information
PCT FiledOctober 19, 2017PCT Application Number:PCT/US2017/057385
PCT Publication Date:April 26, 2018PCT Publication Number: WO2018/075767

International Family Members for US Patent 10,961,190

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 110582486 ⤷  Subscribe
China 117903083 ⤷  Subscribe
Denmark 3529236 ⤷  Subscribe
European Patent Office 3529236 ⤷  Subscribe
Japan 2019531321 ⤷  Subscribe
Japan 2022186979 ⤷  Subscribe
South Korea 102660864 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.